BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15972239)

  • 21. Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors.
    Hara R; Itami J; Kondo T; Aruga T; Uno T; Sasano N; Ohnishi K; Kiyozuka M; Fuse M; Ito M; Naoi K; Kohno Y
    Cancer; 2006 Mar; 106(6):1347-52. PubMed ID: 16475150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation therapy for Bowen's disease of the skin.
    Lukas VanderSpek LA; Pond GR; Wells W; Tsang RW
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):505-10. PubMed ID: 16168842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
    Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
    Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries.
    Baumann P; Nyman J; Lax I; Friesland S; Hoyer M; Rehn Ericsson S; Johansson KA; Ekberg L; Morhed E; Paludan M; Wittgren L; Blomgren H; Lewensohn R
    Acta Oncol; 2006; 45(7):787-95. PubMed ID: 16982541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors.
    Higuchi Y; Serizawa T; Nagano O; Matsuda S; Ono J; Sato M; Iwadate Y; Saeki N
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1543-8. PubMed ID: 19135317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma.
    Hara W; Loo BW; Goffinet DR; Chang SD; Adler JR; Pinto HA; Fee WE; Kaplan MJ; Fischbein NJ; Le QT
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):393-400. PubMed ID: 18164839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC).
    Zimmermann FB; Geinitz H; Schill S; Thamm R; Nieder C; Schratzenstaller U; Molls M
    Acta Oncol; 2006; 45(7):796-801. PubMed ID: 16982542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC).
    Hof H; Muenter M; Oetzel D; Hoess A; Debus J; Herfarth K
    Cancer; 2007 Jul; 110(1):148-55. PubMed ID: 17516437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pulmonary resections for metastatic renal cell carcinoma in Iceland].
    Oddsson SJ; Isaksson HJ; Jonsson E; Einarsson GV; Gudbjartsson T
    Laeknabladid; 2008 May; 94(5):377-81. PubMed ID: 18460734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome.
    van der Voort van Zyp NC; Prévost JB; Hoogeman MS; Praag J; van der Holt B; Levendag PC; van Klaveren RJ; Pattynama P; Nuyttens JJ
    Radiother Oncol; 2009 Jun; 91(3):296-300. PubMed ID: 19297048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC; Cheville JC; Lohse CM; Zincke H; Frank I; Kwon ED; Merchan JR; Blute ML
    J Urol; 2005 Nov; 174(5):1759-63; discussion 1763. PubMed ID: 16217278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological features and surgical outcome of isolated metastasis of renal cell carcinoma.
    Akatsu T; Shimazu M; Aiura K; Ito Y; Shinoda M; Kawachi S; Tanabe M; Ueda M; Kitajima M; Kitagawa Y
    Hepatogastroenterology; 2007 Sep; 54(78):1836-40. PubMed ID: 18019729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
    Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
    Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors.
    Yoon SM; Choi EK; Lee SW; Yi BY; Ahn SD; Shin SS; Park HJ; Kim SS; Park JH; Song SY; Park CI; Kim JH
    Acta Oncol; 2006; 45(8):1108-14. PubMed ID: 17118847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.
    Méndez Romero A; Wunderink W; Hussain SM; De Pooter JA; Heijmen BJ; Nowak PC; Nuyttens JJ; Brandwijk RP; Verhoef C; Ijzermans JN; Levendag PC
    Acta Oncol; 2006; 45(7):831-7. PubMed ID: 16982547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
    Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiosurgery/stereotactic radiotherapy in the therapeutical concept for skull base meningiomas.
    Hamm K; Henzel M; Gross MW; Surber G; Kleinert G; Engenhart-Cabillic R
    Zentralbl Neurochir; 2008 Feb; 69(1):14-21. PubMed ID: 18393160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
    Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence.
    Eggener SE; Yossepowitch O; Pettus JA; Snyder ME; Motzer RJ; Russo P
    J Clin Oncol; 2006 Jul; 24(19):3101-6. PubMed ID: 16809736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
    Rusthoven KE; Kavanagh BD; Burri SH; Chen C; Cardenes H; Chidel MA; Pugh TJ; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1579-84. PubMed ID: 19255320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.